Fundz

INVO Fertility acquires Family Beginnings clinic

PUBLIC · IVFFeb 19, 2026

Acquiring Company

INVO Bioscience

Acquired Company

Family Beginnings P.C

SarasotaIndianapolisBiotechnologyHealthcareHealth CareMedicalHealth CareNon ProfitFamily

Description

INVO Fertility has completed the acquisition of Family Beginnings for $760,000. This strategic move aims to enhance access to quality fertility care while maintaining continuity with existing care teams. Family Beginnings will continue its operations under the leadership of Dr. James Donahue, strengthening INVO's network of fertility care centers.

Who to call at INVO Bioscience, and when

When INVO Bioscience changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day INVO Bioscience raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at INVO Bioscience, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at INVO Bioscience. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

INVO Bioscience

Location

5582 BROADCAST COURT

Sarasota, Florida, United States

About

At INVO bioscience, we are democratizing fertility. Our mission is to help people realize the dream of parenthood by increasing worldwide access to an efficient, effective, and connected experience in reproductive treatment. We are the manufacturers of INVOcell. The first and only FDA cleared, CE marked medical device used in intravaginal culture (IVC). INVOcell holds the gametes within the woman’s body during fertilization and early embryo development. A safe, intimate way for women to be connected right from the very beginning. With INVOcell, Life Begins Within™. We are looking for partners to help us bring treatment where it’s needed. We offer full-service partnerships including resources, training, clinical and lab support. Contact us to learn how you can join the movement to make advanced fertility care within reach.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment INVO Bioscience makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Bojan
Senior decision-maker at this company
••••••••@••••••••

See Bojan's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for INVO Bioscience's next move

Learn about Strategic plan

Frequently asked

Who acquired Family Beginnings P.C?

Family Beginnings P.C was acquired by INVO Bioscience, based in Sarasota. The deal was reported on February 19, 2026. At INVO bioscience, we are democratizing fertility. INVO Bioscience is publicly traded (IVF) and operates in Biotechnology.

When did INVO Bioscience acquire Family Beginnings P.C?

INVO Bioscience's acquisition of Family Beginnings P.C was reported on February 19, 2026. INVO Fertility has completed the acquisition of Family Beginnings for $760,000. This strategic move aims to enhance access to quality fertility care while maintaining continuity with existing care teams. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Family Beginnings P.C do?

Family Beginnings is a fertility clinic that has served patients across Indiana and the broader Midwest since the late 1990s. The clinic is known for its personalized care model and strong success rates in reproductive services. It is privately held, operating in Health Care, and is based in Indianapolis.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.